Naurahyani Syifa Salsabila
Department of Food Technology, Faculty of Engineering and Science, Universitas Pembangunan Nasional Veteran Jawa Timur, Surabaya, 60294, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Computational Screening of Shrimp Proteins Relevant to Terasi Identifies Candidate DPP-IV Inhibitory Peptides Jariyah Jariyah; Naurahyani Syifa Salsabila; Dina Mustika Rini; Muhammad Alfid Kurnianto
Jurnal Ilmiah Perikanan dan Kelautan Vol. 18 No. 3 (2026): JURNAL ILMIAH PERIKANAN DAN KELAUTAN
Publisher : Faculty of Fisheries and Marine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jipk.v18i3.92761

Abstract

Graphical Abstract Highlight Research 1. Integrated in silico framework computationally prioritized potential antidiabetic peptide candidates relevant to Indonesian shrimp paste (terasi). 2. Shrimp proteins, particularly myosin, actin, and haemocyanin, were predicted as major bioactive peptide precursors. 3. Microbial enzymatic hydrolysis generated peptides with high predicted bioactivity and DPP-IV inhibitory potential. 4. Predicted non-toxic peptide candidates relevant to terasi showed favorable computational interaction profiles with the DPP-IV receptor. 5. This study provides molecular insights into fermented seafood as a source of functional antidiabetic ingredients.   Abstract Type 2 diabetes mellitus has stimulated interest in food-derived bioactive peptides as potential antidiabetic compounds. Terasi, a traditional fermented shrimp paste, may contain peptides released through microbial proteolysis, yet candidate dipeptidyl peptidase-IV (DPP-IV) inhibitors relevant to this product remain poorly characterized. This study computationally screened shrimp protein precursors to identify and prioritize potential DPP-IV inhibitory peptides. Selected precursors included myosin, actin, troponin, and haemocyanin proteins retrieved from UniProtKB. Protein sequences from Penaeus vannamei underwent two simulated microbial proteolysis scenarios, followed by bioactivity mapping, toxicity and physicochemical prediction, structural modelling, and molecular docking against human DPP-IV using AutoDock Vina and GNINA. The simulations represented enzymes associated with dominant fermentation microorganisms, with the second additionally incorporating enzymes associated with potential contaminants. Antidiabetic activity was the predominant predicted bioactivity, with occurrence frequencies of 0.339–0.437; DPP-IV inhibition was the most frequent predicted antidiabetic mechanism (0.269–0.395). Further screening identified four peptides-VPPHL, PHAIL, ALPPGV, and MAMMAG-predicted to be non-toxic and possessing favourable physicochemical properties. Their predicted docking energies ranged from −6.9 to −8.8 kcal mol⁻¹ with AutoDock Vina and −6.27 to −9.40 kcal mol⁻¹ with GNINA, with interactions involving residues in the DPP-IV binding region. Docking profiles were also compared with the reference inhibitor sitagliptin, without equating predicted binding with measured inhibition. These results prioritize four computational candidates rather than demonstrating antidiabetic efficacy or their presence in fermented terasi. Confirmation requires direct peptide detection in terasi, in vitro biochemical assessment of DPP-IV inhibition, and evaluation of stability, bioavailability, and safety before functional relevance can be established.